---
title: Remdesivir Enters Clinical Trials as COVID-19 Treatment
description: Remdesivir Enters Clinical Trials as COVID-19 Treatment
---

[News ](https://www.yourway.com/news)

# [Remdesivir Enters Clinical Trials as COVID-19 Treatment](https://www.yourway.com/news/remdesivir-enters-clinical-trials-as-covid-19-treatment)

 Written by [Yourway](https://www.yourway.com/news/author/yourway) | April 13, 2020

Gilead Sciences has [initiated](https://www.gilead.com/purpose/advancing-global-health/covid-19/remdesivir-clinical-trials) two Phase 3 clinical studies to evaluate the safety and efficacy of remdesivir in adults diagnosed with COVID-19 following the FDA’s rapid review and acceptance of Gilead’s IND filing. Enrollment of the clinical trial began in March — at present, 1000 participants will be entered into the trial. Yourway is committed to advancing trials and has full DTP capacity, which is particularly relevant given the stay-home-orders in place across countries and states.

[View full post](https://www.yourway.com/news/remdesivir-enters-clinical-trials-as-covid-19-treatment)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Yourway"
  },
  "dateModified" : "2020-04-13T09:00:00.381Z",
  "datePublished" : "2020-04-13T09:00:00Z",
  "headline" : "Remdesivir Enters Clinical Trials as COVID-19 Treatment",
  "image" : {
    "@type" : "ImageObject",
    "height" : 4039,
    "url" : "https://cdn2.hubspot.net/hubfs/5402331/iStock-1208239546.jpg",
    "width" : 6055
  },
  "mainEntityOfPage" : "https://www.yourway.com/news/remdesivir-enters-clinical-trials-as-covid-19-treatment",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "News"
  }
}
```